Group President - Vaccines, Oncology and Consumer Healthcare Business
Mr. Albert Bourla was appointed as Group President Vaccines, Oncology and Consumer Healthcare Business, Global Innovative Pharma Business of the Company. He was President and General Manager of Established Products Business Unit from December 2010 until December 2013. Area President Europe, Africa, Asia and Pacific of Pfizer Animal Health from 2009 until November 2010. Area President Europe, Africa and Middle East of Pfizer Animal Health from 2005 until 2009.
Age: 52 President Since 2016
212 733-2323 www.pfizer.com
Albert Bourla Latest Insider Trades
The company has Return on Asset of 0.05 %
which means that on every $100 spent on asset it made $0.05 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE)
of 10.0 %
implying that it generated $10.0 on every 100 dollars invested.
The company has 38.9 B in debt with debt to equity (D/E) ratio of 0.69 which is OK given its current industry classification. Pfizer Inc has Current Ratio of 1.09 demonstrating that it may have difficulties to pay its financial commitments when the payables are due.
Pfizer Inc. discovers, develops, manufactures, and sells healthcare solutions worldwide. Pfizer Inc (PFE) is traded on New York Stock Exchange in USA. It is located in NEW YORK, U.S.A and employs 97,900 people. Pfizer is listed under Pharmaceutical Products category by Fama And French industry classification and specializes in Healthcare
with concentration in Pharmaceuticals And Biosciences